Levosimendan attenuates pulmonary vascular remodeling.
Revermann M, Schloss M, Mieth A, Babelova A, Schröder K, Neofitidou S, Buerkl J, Kirschning T, Schermuly RT, Hofstetter C, Brandes RP.
Revermann M, et al.
Intensive Care Med. 2011 Aug;37(8):1368-77. doi: 10.1007/s00134-011-2254-9. Epub 2011 May 31.
Intensive Care Med. 2011.
PMID: 21626431
Clinical Trial.